Plain-English translation of NCT07382284 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that follows patients with end-stage heart failure who receive a left ventricular assist device (LVAD)—a surgically implanted mechanical heart pump. Researchers will track your health, hospital visits, and long-term survival over 3–5 years to better understand how patients do after receiving this device and identify biological factors that may predict recovery.
While the mechanical heart pump is an established treatment for severe heart failure, doctors need more detailed information about how patients fare in the long term after implantation and what biological changes in the heart may affect outcomes. This study aims to improve future care and treatment decisions for patients with end-stage heart failure.
You likely qualify if…
You likely don't qualify if…
You will receive your heart pump device as part of your standard medical care. The study collects tissue samples routinely removed during your surgery and blood samples taken during your regular medical visits—no extra procedures needed. Your doctors will track your health, medications, hospital visits, and survival status over 3–5 years, with all follow-up care managed by your treating physicians as usual.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China